RU2017120815A3 - - Google Patents

Download PDF

Info

Publication number
RU2017120815A3
RU2017120815A3 RU2017120815A RU2017120815A RU2017120815A3 RU 2017120815 A3 RU2017120815 A3 RU 2017120815A3 RU 2017120815 A RU2017120815 A RU 2017120815A RU 2017120815 A RU2017120815 A RU 2017120815A RU 2017120815 A3 RU2017120815 A3 RU 2017120815A3
Authority
RU
Russia
Application number
RU2017120815A
Other versions
RU2017120815A (ru
RU2679836C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017120815A3 publication Critical patent/RU2017120815A3/ru
Publication of RU2017120815A publication Critical patent/RU2017120815A/ru
Application granted granted Critical
Publication of RU2679836C2 publication Critical patent/RU2679836C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
RU2017120815A 2015-04-28 2016-04-28 Композиция среды для получения ботулинического токсина RU2679836C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020150059656A KR101723168B1 (ko) 2015-04-28 2015-04-28 보툴리눔 독소의 제조를 위한 배지 조성물
KR10-2015-0059656 2015-04-28
PCT/KR2016/004432 WO2016175567A1 (en) 2015-04-28 2016-04-28 Medium composition for preparing botulinum toxin

Publications (3)

Publication Number Publication Date
RU2017120815A3 true RU2017120815A3 (ru) 2018-12-14
RU2017120815A RU2017120815A (ru) 2018-12-14
RU2679836C2 RU2679836C2 (ru) 2019-02-13

Family

ID=57199572

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017120815A RU2679836C2 (ru) 2015-04-28 2016-04-28 Композиция среды для получения ботулинического токсина

Country Status (13)

Country Link
US (1) US10308923B2 (ru)
EP (1) EP3289071A4 (ru)
JP (2) JP2018500881A (ru)
KR (1) KR101723168B1 (ru)
CN (1) CN107002026A (ru)
AR (1) AR104418A1 (ru)
AU (1) AU2016253790B2 (ru)
BR (1) BR112017012893A2 (ru)
CA (1) CA2968050A1 (ru)
MX (1) MX2017008198A (ru)
RU (1) RU2679836C2 (ru)
TW (1) TWI592486B (ru)
WO (1) WO2016175567A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723167B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558926B1 (en) * 1999-07-16 2003-05-06 Massachusetts Institute Of Technology Method for production of tetanus toxin using media substantially free of animal products
US7148041B2 (en) * 2003-09-25 2006-12-12 Allergan, Inc. Animal product free media and processes for obtaining a botulinum toxin
US7160699B2 (en) 2003-09-25 2007-01-09 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
RU2255761C1 (ru) 2004-07-01 2005-07-10 Общество с ограниченной ответственностью "Токсины и сопутствующие продукты" Препарат для лечения мышечных дистоний из токсина культуры clostridium botulinum и способ его получения
WO2006042542A2 (en) 2004-10-19 2006-04-27 Statens Serum Institut Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
BRPI0508299A (pt) * 2005-03-03 2007-07-31 Allergan Inc sistema livre de produto animal e processo para purificação de uma toxina botulina
WO2007037849A2 (en) * 2005-09-16 2007-04-05 Allergan, Inc. Compositions and methods for the intraocular transport of therapeutic agents
KR100680318B1 (ko) * 2005-12-16 2007-02-08 최성현 미생물 배양용 영양배지
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
FR2918671B1 (fr) * 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
KR20090120222A (ko) * 2008-05-19 2009-11-24 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법
KR101723167B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101729251B1 (ko) * 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101775682B1 (ko) * 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
KR20160127999A (ko) 2016-11-07
EP3289071A1 (en) 2018-03-07
WO2016175567A1 (en) 2016-11-03
US20170260515A1 (en) 2017-09-14
JP2018500881A (ja) 2018-01-18
RU2017120815A (ru) 2018-12-14
KR101723168B1 (ko) 2017-04-05
TW201638330A (zh) 2016-11-01
AR104418A1 (es) 2017-07-19
BR112017012893A2 (pt) 2018-01-30
US10308923B2 (en) 2019-06-04
EP3289071A4 (en) 2018-10-31
AU2016253790B2 (en) 2018-11-29
CN107002026A (zh) 2017-08-01
CA2968050A1 (en) 2016-11-03
TWI592486B (zh) 2017-07-21
AU2016253790A1 (en) 2017-05-25
JP2020022436A (ja) 2020-02-13
MX2017008198A (es) 2017-09-13
RU2679836C2 (ru) 2019-02-13

Similar Documents

Publication Publication Date Title
BR112017026333A2 (ru)
BR112018005697A2 (ru)
RU2017120813A3 (ru)
RU2017120815A3 (ru)
BR112018005585A2 (ru)
BE2015C047I2 (ru)
BE2015C044I2 (ru)
CN303089688S (ru)
CN303069082S (ru)
BR0001536B1 (ru)
BR0001810B1 (ru)
BR0002033B1 (ru)
BR0000763F1 (ru)
BR0002402B1 (ru)
BR0002435B1 (ru)
BR0002694B1 (ru)
BR0002802B1 (ru)
BR0009373B1 (ru)
BR0002874B1 (ru)
BR0003166B1 (ru)
CN303113830S (ru)
CN303113577S (ru)
BR0003189B1 (ru)
CN303107674S (ru)
BR0009349B1 (ru)